P053 Interstitial Nephritis from IBD: Complicated Conclusions

Area of Science:

• Nephrology
• Gastroenterology
• Immunology

Background:

• Kidney injury presents a significant challenge in managing patients with inflammatory bowel disease (IBD).
• Tubulointerstitial nephritis (TIN) is a known complication of aminosalicylates but has also been observed in drug-naïve IBD patients, suggesting a potential direct link to IBD itself.
• Differentiating the etiology of TIN in IBD patients is clinically challenging due to multiple confounding factors.

Purpose of the Study:

• To describe three challenging cases of tubulointerstitial nephritis (TIN) in patients with inflammatory bowel disease (IBD).
• To illustrate the diagnostic difficulties in attributing renal injury to either IBD medications or the underlying disease process.
• To highlight the limitations of current diagnostic tools, including renal biopsy and nephrology consultation, in determining the cause of TIN in this population.

Main Methods:

• Presentation of three distinct cases of IBD patients who developed acute kidney injury.
• Detailed review of patient histories, including IBD type, medications (aminosalicylates, biologics, immunosuppressants), comorbidities, and clinical presentation.
• Analysis of renal biopsy findings, diagnostic workups, and nephrology consultations for each case.
• Discussion of the differential diagnoses for TIN, including drug-induced injury, infection, sarcoidosis, and IBD as an extra-intestinal manifestation.

Main Results:

• In all three cases, the etiology of TIN remained uncertain despite extensive investigation, including renal biopsies.
• Nephrology consultations and biopsies did not definitively distinguish between medication-induced injury and IBD as the cause of renal damage.
• Patients presented with varying degrees of acute and chronic TIN, with features suggestive of drug hypersensitivity, infection, or IBD-related processes.
• Confounding factors such as hypertension and multiple concomitant medications complicated the diagnostic process in all cases.

Conclusions:

• The diagnosis of tubulointerstitial nephritis (TIN) in inflammatory bowel disease (IBD) patients is often ambiguous, with diagnostic challenges persisting even after renal biopsy.
• Current diagnostic approaches may not adequately differentiate between medication side effects and IBD as the primary cause of renal injury.
• Further research is needed to develop more definitive methods for diagnosing the etiology of TIN in IBD patients, especially considering the increasing use of biologic therapies like adalimumab and vedolizumab.